Patient info Open main menu

N04BC05 pramipexole

ATC group of level 5 – chemical substance · in plain English: medicines for Parkinson's disease

This site has the patient leaflet or the SPC of 70 medicines in this group.

Active substance: Pramipexole – all medicines with this substance, also in combinations.

Place in the ATC classification

  1. N Nervous system drugs 4,479 medicines
    1. N04 Anti-parkinson drugs 315 medicines
      1. N04B Dopaminergic agents 292 medicines
        1. N04BC Dopamine agonists 161 medicines
          1. N04BC05 pramipexole 70 medicines

Medicines

MedicineLegal category
Glepark 0.088 mg tablets SPC –
Glepark 0.18 mg tablets SPC Prescription only (POM)
Glepark 0.35 mg tablets SPC Prescription only (POM)
Glepark 0.7 mg tablets SPC Prescription only (POM)
Mirapexin 0.088 mg tablets SPC Prescription only (POM)
Mirapexin 0.180 mg tablets SPC Prescription only (POM)
Mirapexin 0.26 mg prolonged-release tablets SPC Prescription only (POM)
Mirapexin 0.35 mg tablets SPC Prescription only (POM)
Mirapexin 0.52 mg prolonged-release tablets SPC Prescription only (POM)
Mirapexin 0.7 mg tablets SPC Prescription only (POM)
Mirapexin 1.05 mg prolonged-release tablets SPC Prescription only (POM)
Mirapexin 1.57 mg prolonged-release tablets SPC Prescription only (POM)
Mirapexin 2.1 mg prolonged-release tablets SPC Prescription only (POM)
Mirapexin 2.62 mg prolonged-release tablets SPC Prescription only (POM)
Mirapexin 3.15 mg prolonged-release tablets SPC Prescription only (POM)
Oprymea SPC Prescription only (POM)
Oprymea 0.088 mg tablets SPC Prescription only (POM)
Oprymea 0.18 mg tablets SPC Prescription only (POM)
Oprymea 0.26 mg + 0.52 mg + 1.05 mg prolonged-release tablets SPC –
Oprymea 0.26 mg prolonged-release tablets SPC Prescription only (POM)
Oprymea 0.52 mg prolonged-release tablets Prescription only (POM)
Oprymea 0.7 mg tablets SPC Prescription only (POM)
Oprymea 1.05 mg prolonged-release tablets SPC Prescription only (POM)
Oprymea 1.57 mg prolonged-release tablets SPC Prescription only (POM)
Oprymea 2.6 mg prolonged-release tablets SPC Prescription only (POM)
Oprymea 3.15 mg prolonged-release tablets SPC Prescription only (POM)
Pipexus 0.26 mg prolonged-release tablets SPC Prescription only (POM)
Pipexus 0.52 mg prolonged-release tablets SPC Prescription only (POM)
Pipexus 1.05 mg prolonged-release tablets SPC Prescription only (POM)
Pipexus 1.57 mg prolonged-release tablets SPC Prescription only (POM)
Pipexus 2.1 mg prolonged-release tablets SPC Prescription only (POM)
Pipexus 2.62 mg prolonged-release tablets SPC Prescription only (POM)
Pipexus 3.15 mg prolonged-release tablets SPC Prescription only (POM)
Pramipexole 0.088 mg tablets SPC Prescription only (POM)
Pramipexole 0.18 mg tablets SPC Prescription only (POM)
Pramipexole 0.35 mg tablets SPC no longer supplied –
Pramipexole 0.7 mg tablets SPC no longer supplied –
Pramipexole 1.1 mg tablets SPC –
Pramipexole 180 micrograms tablets SPC Prescription only (POM)
Pramipexole 350 micrograms tablets SPC Prescription only (POM)
Pramipexole 700 micrograms tablets SPC Prescription only (POM)
Pramipexole 88 micrograms tablets SPC Prescription only (POM)
Pramipexole Accord SPC –
Pramipexole Krka 2.1 mg prolonged-release tablets Prescription only (POM)
Pramipexole Mylan 0.088 mg tablets SPC Prescription only (POM)
Pramipexole Mylan 0.18 mg tablets SPC no longer supplied –
Pramipexole Mylan 0.26 mg prolonged-release tablets SPC Prescription only (POM)
Pramipexole Mylan 0.35 mg tablets Prescription only (POM)
Pramipexole Mylan 0.52 mg prolonged-release tablets SPC Prescription only (POM)
Pramipexole Mylan 0.7 mg tablets SPC no longer supplied –
Pramipexole Mylan 1.05 mg prolonged-release tablets SPC Prescription only (POM)
Pramipexole Mylan 1.57 mg prolonged-release tablets SPC Prescription only (POM)
Pramipexole Mylan 2.1 mg prolonged-release tablets SPC Prescription only (POM)
Pramipexole Mylan 2.62 mg prolonged-release tablets SPC Prescription only (POM)
Pramipexole Mylan 3.15 mg prolonged-release tablets SPC Prescription only (POM)
Pramipexole Teva 0.26 mg prolonged-release tablets SPC Prescription only (POM)
Pramipexole Teva 0.52 mg prolonged-release tablets SPC Prescription only (POM)
Pramipexole Teva 1.05 mg prolonged-release tablets SPC Prescription only (POM)
Pramipexole Teva 1.57 mg prolonged-release tablets SPC Prescription only (POM)
Pramipexole Teva 2.1 mg prolonged-release tablets SPC Prescription only (POM)
Pramipexole Teva 2.62 mg prolonged-release tablets SPC Prescription only (POM)
Pramipexole Teva 3.15 mg prolonged-release tablets SPC Prescription only (POM)
Pramipexole Zentiva 0.26 mg prolonged-release tablets SPC no longer supplied –
Pramipexole Zentiva 0.52 mg prolonged-release tablets SPC no longer supplied –
Pramipexole Zentiva 1.05 mg prolonged-release tablets SPC no longer supplied –
Pramipexole Zentiva 1.57 mg prolonged-release tablets SPC Prescription only (POM)
Pramipexole Zentiva 2.10 mg prolonged-release tablets SPC Prescription only (POM)
Pramipexole Zentiva 2.62 mg prolonged-release tablets SPC no longer supplied –
Pramipexole Zentiva 3.15 mg prolonged-release tablets SPC no longer supplied –
Sifrol SPC no longer supplied –

Other groups of the same level

Other names of the ATC group

Sources

  • Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
  • Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
  • World Health Organization (WHO): ATC/DDD classification, group N04BC05

Contains public sector information licensed under the Open Government Licence v3.0.

Ask your doctor or pharmacist which medicine is right for you.